Cardiovascular diseases Trials in Cleveland, United States
Conditions / Cardiovascular diseases / Cleveland, United States
Clinical trials for Cardiovascular diseases investigate a range of treatment strategies and patient populations.
53 total trials for this combination
Showing top 10 of 53 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01471522 | International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) | COMPLETED | NA |
| NCT02638129 | Naltrexone/Bupropion Cardiovascular Outcomes Study | TERMINATED | PHASE4 |
| NCT02993406 | Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo | COMPLETED | PHASE3 |
| NCT05882045 | A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00000620 | Action to Control Cardiovascular Risk in Diabetes (ACCORD) | COMPLETED | PHASE3 |
| NCT00153101 | Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo. | COMPLETED | PHASE4 |
| NCT00324350 | Intensive Glycemic Control and Skeletal Health Study | COMPLETED | PHASE3 |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT05198674 | SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN | ACTIVE_NOT_RECRUITING | — |
| NCT05198674 | SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN | ACTIVE_NOT_RECRUITING | — |